scholarly article | Q13442814 |
P50 | author | Maxime Dougados | Q63136268 |
Astrid van Tubergen | Q83113550 | ||
Annelies Boonen | Q91062233 | ||
Sofia Ramiro | Q39184066 | ||
Robert Landewé | Q47264015 | ||
P2093 | author name string | Filip Van den Bosch | |
Anneke Spoorenberg | |||
Suzanne Arends | |||
Valéria Lima Passos | |||
Desirée van der Heijde | |||
Freke R Wink | |||
Maike Imkamp | |||
P2860 | cites work | Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study | Q47355075 |
Which aspects of health are most important for patients with spondyloarthritis? A Best Worst Scaling based on the ASAS Health Index | Q47418606 | ||
Comorbidities in Spondyloarthritis associate with poor function, work disability and quality of life: Results from the ASAS-COMOSPA study. | Q47617915 | ||
Social role participation and satisfaction with life: A study among patients with ankylosing spondylitis and population controls | Q47819749 | ||
Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort | Q48572011 | ||
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. | Q51848130 | ||
Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis. | Q53037194 | ||
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. | Q53212276 | ||
Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis | Q79696620 | ||
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores | Q82414520 | ||
The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study | Q87497578 | ||
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis) | Q24186403 | ||
TNF-alpha inhibitors for ankylosing spondylitis | Q24186462 | ||
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis | Q24674389 | ||
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index | Q28299001 | ||
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis | Q33860755 | ||
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria | Q34055060 | ||
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index | Q34307327 | ||
Predicting the outcome of ankylosing spondylitis therapy | Q34905433 | ||
Socioeconomic consequences of ankylosing spondylitis | Q35015332 | ||
Withdrawal from labour force due to work disability in patients with ankylosing spondylitis | Q35549928 | ||
Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study | Q35557916 | ||
Five Potentially Modifiable Factors Predict Poor Quality of Life in Ankylosing Spondylitis: Results from the Scotland Registry for Ankylosing Spondylitis. | Q38648071 | ||
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force | Q38690324 | ||
Patient-reported Flares in Ankylosing Spondylitis: A Cross-sectional Analysis of 234 Patients | Q39097247 | ||
The co-occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: Results from a UK national register (BSRBR-AS). | Q40157050 | ||
Disease activity trajectories in early axial spondyloarthritis: results from the DESIR cohort. | Q40456866 | ||
Quality of life and correlation with clinical and radiographic variables in patients with ankylosing spondylitis: a retrospective case series study. | Q41431578 | ||
Introducing the fit-criteria assessment plot - A visualisation tool to assist class enumeration in group-based trajectory modelling | Q41490584 | ||
Role of contextual factors in health-related quality of life in ankylosing spondylitis | Q44781334 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | quality of life | Q13100823 |
P304 | page(s) | e000755 | |
P577 | publication date | 2018-01-01 | |
P1433 | published in | RMD open | Q27726913 |
P1476 | title | Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life | |
P478 | volume | 4 |
Search more.